Imagine Pharmaceuticals

Imagine Pharma is a biotechnology company focused on the development of oral delivery systems for biologics and the treatment of metabolic and autoimmune diseases. The company's proprietary IMG-1 platform utilizes a unique A-B-A polypeptide structure to enable the oral administration of drugs that typically require injection, such as insulin and GLP-1 agonists. Their lead programs target Type 1 Diabetes and Inflammatory Bowel Disease, aiming to improve patient compliance and therapeutic outcomes. Based in Pittsburgh, the company leverages its platform to address significant unmet needs in regenerative medicine and chronic disease management. Imagine Pharma is currently advancing its pipeline toward clinical trials following a successful Series A funding round.